ArticleHealth science reports2025
The Growing Mpox Infections by Clade I Variant in African Countries Is a Public Health Emergency of International Concern: A Narrative Review.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- An Mpox 2024 Survey of Health Sciences Students in India and Bangladesh.Journal of community health · 2026Article
- Exploring monkeypox virus antibody levels: insights from human immunological research.Virology journal · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: In 2022, the monkeypox (mpox) outbreak was declared a public health emergency of international concern. The emergence of a new strain in the Democratic Republic of the Congo and its identification with neighboring countries led to the declaration of a public health emergency in 2024. The objective is to focus on the recent outbreak that led to its declaration as a Public Health Emergency of International Concern, assess the significant global public health threat posed by the newly identified class, and explore effective strategies to address this situation. Methods: The present review searched information from databases (PubMed and Scopus), WHO, and the European Centre for Disease Prevention and Control. The search methods followed database-specific criteria. Key terms included mpox, prevalence, public health emergency, treatment, new variant, prevention, and strategy. We reviewed and extracted information from the relevant literature. Results: Mpox has been endemic in the Democratic Republic of the Congo for over a decade, with a consistent annual rise in reported cases. In August 2024, at least 13 African countries have confirmed 2,863 cases and 517 fatalities. The recent emergence and transmission of a new strain, which appears to be predominantly spreading through sexual networks, along with its identification in neighboring countries, raises significant concerns for public health. Conclusion: The emergence of the new clade of mpox represents a critical public health challenge that necessitates immediate and coordinated global response efforts. By addressing the current outbreak comprehensively, we can mitigate its impact and safeguard public health across affected regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.